On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...